CWM
CELG

Cranbrook Wealth Management’s Celgene Corp CELG Stock Holding History

Cranbrook Wealth Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-92
Closed -$9K – 303
2019
Q3 		$9K Hold
92
– – ﹤0.01% 203
2019
Q2 		$9K Hold
92
– – ﹤0.01% 197
2019
Q1 		$9K Hold
92
– – ﹤0.01% 199
2018
Q4 		$6K Hold
92
– – ﹤0.01% 198
2018
Q3 		$8K Hold
92
– – ﹤0.01% 191
2018
Q2 		$7K Buy
+92
New +$7.64K ﹤0.01% 187

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Cranbrook Wealth Management's CELG Position: Q4 2019 in Review

Cranbrook Wealth Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 92 shares — an estimated $9K sold.

Cranbrook Wealth Management first reported a position in CELG in Q2 2018 and held it in 6 quarters. The position peaked at $9K in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Cranbrook Wealth Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Cranbrook Wealth Management sold 92 Celgene Corp shares in Q4 2019, an estimated $9K.
  • Cranbrook Wealth Management first reported a position in Celgene Corp in Q2 2018 and held it in 6 quarters.
  • Cranbrook Wealth Management's Celgene Corp position peaked at $9K in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Cranbrook Wealth Management's 13F filing for Q4 2019, filed 11 Feb 2020.